METTL14 knockdown attenuates neuron injury and improves function recovery after spinal cord injury via regulating FGF21 in a m6A-IGF2BP1 dependent mechanism
Abstract
Background: Fibroblast growth factor 21 (FGF21) and Methyltransferase-like 14 (METTL14) have been identified to be involved in spinal cord injury (SCI). However, whether FGF21 functioned in SCI via METTL14-induced N6-methyladenosine (m6A) modification remains unclear.
Materials and methods: PC12 cells were exposed to lipopolysaccharide (LPS) in vitro. qRT-PCR and western blotting analyses were applied to detect the mRNA and protein levels of METTL14, FGF21 and Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). The CCK-8 assay, EdU assay, flow cytometry and ELISA analysis were used to conduct in vitro functional analyses. Cell ferroptosis was assessed by measuring the levels of Fe2+, reactive oxygen species, glutathione and related regulators. The N6-methyladenosine (m6A) modification profile was analyzed by methylated RNA immunoprecipitation (MeRIP) assay. The interaction between IGF2BP1 and FGF21 was validated using RIP assay. SCI animal models were constructed for in vivo analysis.
Results: Levels of FGF21 were decreased in LPS-induced PC12 cells. Functionally, FGF21 overexpression reversed LPS-induced proliferation inhibition, apoptosis, ferroptosis and inflammation in PC12 cells. Mechanistically, METTL14 induced FGF21 m6A modification in SCI cell models, and m6A-binding protein IGF2BP1 was involved in regulating FGF21 expression by METTL14. METTL14 silencing abolished LPS-induced neuronal apoptosis, inflammation and ferroptosis via regulating FGF21. Moreover, METTL14 silencing improved neuronal injury in SCI rat models by modulating FGF21 expression.
Conclusions: METTL14 knockdown attenuates neuron injury and improves function recovery after SCI via up-regulating FGF21 in an m6A-IGF2BP1 dependent mechanism, suggesting a useful target for SCI recovery.
Keywords: m6ASCIferroptosisneuroinflammationFGF21METTL14GPX4
References
- Adams AC, Yang C, Coskun T, et al. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol Metab. 2012; 2(1): 31–37.
- Ahuja CS, Wilson JR, Nori S, et al. Traumatic spinal cord injury. Nat Rev Dis Primers. 2017; 3: 17018.
- Anjum A, Yazid MD, Fauzi Daud M, et al. Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 2020; 21(20).
- Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995; 12(1): 1–21.
- Beattie MS, Hermann GE, Rogers RC, et al. Cell death in models of spinal cord injury. Prog Brain Res. 2002; 137: 37–47.
- Dou X, Huang L, Xiao Yu, et al. METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity. Protein Cell. 2023; 14(9): 683–697.
- Eli I, Lerner DP, Ghogawala Z. Acute traumatic spinal cord injury. Neurol Clin. 2021; 39(2): 471–488.
- Flippo KH, Potthoff MJ. Metabolic messengers: FGF21. Nat Metab. 2021; 3(3): 309–317.
- Gao G, Duan Y, Chang F, et al. METTL14 promotes apoptosis of spinal cord neurons by inducing EEF1A2 m6A methylation in spinal cord injury. Cell Death Discov. 2022; 8(1): 15.
- Geng L, Lam KSL, Xu A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol. 2020; 16(11): 654–667.
- Gu Qi, Sha W, Huang Q, et al. Fibroblast growth factor 21 inhibits ferroptosis following spinal cord injury by regulating heme oxygenase-1. Neural Regen Res. 2024; 19(7): 1568–1574.
- Guan Q, Lin H, Miao L, et al. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer. J Hematol Oncol. 2022; 15(1): 13.
- He L, Li H, Wu A, et al. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019; 18(1): 176.
- Jendelova P, Syková E, Jendelová P, et al. Bone marrow stem cells and polymer hydrogels — two strategies for spinal cord injury repair. Cell Mol Neurobiol. 2006; 26(7-8): 1113–1129.
- Li QS, Jia YJ. Ferroptosis: a critical player and potential therapeutic target in traumatic brain injury and spinal cord injury. Neural Regen Res. 2023; 18(3): 506–512.
- Lipinski MM, Wu J, Faden AI, et al. Function and mechanisms of autophagy in brain and spinal cord trauma. Antioxid Redox Signal. 2015; 23(6): 565–577.
- Liu D, Fan B, Li J, et al. N6-methyladenosine modification: a potential regulatory mechanism in spinal cord injury. Front Cell Neurosci. 2022; 16: 989637.
- Liu P, Li F, Lin J, et al. m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype. Nat Cell Biol. 2021; 23(4): 355–365.
- Liu X, Chen C, Han D, et al. SLC7A11/GPX4 inactivation-mediated ferroptosis contributes to the pathogenesis of triptolide-induced cardiotoxicity. Oxid Med Cell Longev. 2022; 2022: 3192607.
- Liu XH, Graham ZA, Harlow L, et al. Spinal cord injury reduces serum levels of fibroblast growth factor-21 and impairs its signaling pathways in liver and adipose tissue in mice. Front Endocrinol (Lausanne). 2021; 12: 668984.
- Nogueira-Rodrigues J, Leite SC, Pinto-Costa R, et al. Rewired glycosylation activity promotes scarless regeneration and functional recovery in spiny mice after complete spinal cord transection. Dev Cell. 2022; 57(4): 440–450.e7.
- Shinozaki M, Nagoshi N, Nakamura M, et al. Mechanisms of stem cell therapy in spinal cord injuries. Cells. 2021; 10(10): 2676.
- Wang C, Zhu X, Chen R, et al. Upregulation of UBR1 m6A methylation by METTL14 inhibits autophagy in spinal cord injury. eNeuro. 2023; 10(6).
- Wang H, Yuan J, Dang X, et al. Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375. Cell Biosci. 2021; 11(1): 52.
- Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007; 99(1): 4–9.
- Adhikari S, Xiao W, Zhao YL, et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016; 61(4): 507–519.
- Xu T, Zhu Q, Huang Q, et al. FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1/β-Klotho pathway. Brain Res Bull. 2023; 202: 110753.
- Yu Yi, Yan Y, Niu F, et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021; 7(1): 193.
- Zhu S, Ying Y, Ye L, et al. Systemic administration of fibroblast growth factor 21 improves the recovery of spinal cord injury (SCI) in rats and attenuates SCI-induced autophagy. Front Pharmacol. 2020; 11: 628369.
